BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:DCY636 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of DCY636\, from ClinicalTrials.gov estimate
 s.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07604324-1348@assetmemo.bio
DTSTAMP:20261121T004550Z
DTSTART;VALUE=DATE:20280127
DTEND;VALUE=DATE:20280128
SUMMARY:DCY636: Phase 1 readout est. (NCT07604324)
DESCRIPTION:DCY636\, phase 1\, Atopic Dermatitis.\nStudy: A First-in-human 
 Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Mult
 iple Doses in Participants With Moderate to Severe Atopic Dermatitis\nEsti
 mated primary completion: 27 January 2028. This is a ClinicalTrials.gov es
 timate\, not a confirmed readout date\, and it can move.\nDrug page: https
 ://assetmemo.bio/drug/dcy636#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT07604324
URL:https://assetmemo.bio/drug/dcy636#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
